Company Search:
Advanced Search
Sponsored Links
Glenmark Pharmaceuticals Ltd Company Snapshot
Glenmark Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glenmark Pharmaceuticals Ltd with three other companies in this sector in India: Piramal Enterprises Limited (2017 sales of 85.04 billion Indian Rupees [US$1.29 billion] of which 47% was Pharmaceuticals), Cadila Healthcare Ltd (94.30 billion Indian Rupees [US$1.44 billion] of which 100% was Pharmaceutical Products), and Jubilant Life Sciences Limited (58.61 billion Indian Rupees [US$892.11 million] of which 53% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2017, sales at Glenmark Pharmaceuticals Ltd were 91.86 billion Indian Rupees (US$1.40 billion). This is an increase of 20.3% versus 2016, when the company's sales were 76.34 billion Indian Rupees. This was the fifth consecutive year of sales increases at Glenmark Pharmaceuticals Ltd (and since 2012, sales have increased a total of 128%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Glenmark Pharmaceuticals Ltd
  Stock Performance Chart for Glenmark Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 571.20
(Figures in Indian Rupees)
1 Week -1.9%   13 Weeks 6.7%  
4 Weeks -8.5%   52 Weeks -36.8%  
Glenmark Pharmaceuticals Ltd Key Data:
  Ticker: GLENMARK Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 91,856,810,000
(Year Ending Jan 2018).
Employees: 12,967
  Currency: Indian Rupees Market Cap: 161,174,450,707
  Fiscal Yr Ends: March Shares Outstanding: 282,168,156
  Share Type: Ordinary Closely Held Shares: 142,686,463
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.